Eloxx Pharmaceuticals (ELOX) Interest Expenses (2017 - 2018)
Eloxx Pharmaceuticals (ELOX) reported Interest Expenses of $43,000 for Q1 2018, down 6.5% from $46,000 a year earlier.
Powered by 
Analysis
Eloxx Pharmaceuticals (ELOX) Interest Expenses (2017 - 2018) Analysis & Trends
Over the twelve months ended Mar 31, 2018, Eloxx Pharmaceuticals' Interest Expenses came in at $89,000, up 93.5% year-over-year.
- By year, Interest Expenses came in at $7,000 in FY2016 (-94.3%) and $122,000 in FY2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.71 Bn | 1,133.30 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 633.37 Bn | 551.90 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 503.99 Bn | 477.10 Bn | 12.70 Bn | - |
| 4 | Merck | 378.19 Bn | 332.57 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 303.15 Bn | 267.14 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 266.17 Bn | 239.85 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 241.38 Bn | 196.78 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 172.31 Bn | 118.96 Bn | 10.94 Bn | - |
| 10 | Eloxx Pharmaceuticals | 92.03 Mn | 18.35 Mn | - | - |
API Access
Eloxx Pharmaceuticals Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ELOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ELOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ELOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();